Arena Pharmaceuticals and 3 Stocks BUZZING Before Earnings Now

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) will unveil its latest earnings today, Thursday, August 9, 2012. The average estimate of analysts is for a loss of 8 cents per share, a narrower loss from the year-earlier quarter net loss of 16 cents. During the past three months, the average estimate has moved up from a loss of 12 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at a loss of 8 cents during the last month.

For the past three quarters, the company’s quarterly results have come in below analyst’s expectations. Last quarter, the company reported net loss of 15 cents per share versus a mean estimate of a loss of 13 cents per share. Analysts predict a rise of more than twofold in revenue from the year-earlier quarter to $7.4 million.

CareFusion Corporation (NYSE:CFN) will unveil its latest earnings on Thursday, August 9, 2012. The average analyst estimate is for net income of 50 cents per share, a decline of 3.8% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 52 cents. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. For the year, analysts are projecting profit of $1.77 per share, a rise of 7.3% from last year.

The company is looking to top estimates for the third straight quarter. Last quarter, it reported net income of 49 cents per share against a mean estimate of profit of 45 cents, and the quarter before, the company exceeded forecasts by one cent with net income of 44 cents versus a mean estimate of profit of 43 cents. Analysts are projecting a decline of 0.3% in revenue from the year-earlier quarter to $960.6 million.

Capstone Turbine Corporation (NASDAQ:CPST) will unveil its latest earnings on Thursday, August 9, 2012. The average estimate of analysts is for net loss of 2 cents per share, a narrower loss from the year-earlier quarter net loss of 3 cents. During the past three months, the average estimate has moved down from a loss of one cent. Between one and three months ago, the average estimate moved down. It has been unchanged at a loss of 2 cents during the last month.

The company showed a loss of 3 cents per share versus a mean estimate of net loss of last quarter. This marks the fourth month of falling short of estimates. Analysts predict a rise of 27.3% in revenue from the year-earlier quarter to $30.9 million.

DeVry Inc. (NYSE:DV) will unveil its latest earnings on Thursday, August 9, 2012. The average analyst estimate is for profit of 47 cents per share, a decline of 56.5% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 80 cents. Between one and three months ago, the average estimate moved down. It also has dropped from 79 cents during the last month. For the year, analysts are projecting net income of $3.21 per share, a decline of 31.4% from last year.

The company met estimates last quarter after falling short of forecasts in the prior two. Before reporting profit of $1 per share in the third quarter to fall in line with expectations, the company beat estimates by 8 cents in the second quarter. On average, analysts predict $506.2 million in revenue this quarter, a decline of 7.4% from the year-ago quarter. Analysts are forecasting total revenue of $2.09 billion for the year, a decline of 4.1% from last year’s revenue of $2.18 billion.